🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, multi-cohort study to investigate safety, anti-tumor act...
Status
Completed
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2021-03-06
Trial ID
NCT04963088
Treatments Being Tested
For HCC patients with PVTT who the researchers believe can benefit from rad...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-05
Trial ID
NCT07363512
Treatments Being Tested
The goal of this clinical trial is to learn if tislelizumab in combination ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2025-07-20
Trial ID
NCT06977828
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of the combine...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07128693
SCLC has short doubling time, high proliferation rate and early widespread ...
Status
Unknown
Location
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start Date
2021-09-30
Trial ID
NCT05027100
Treatments Being Tested
In this study, we propose to use the combination of ET-SPACE NIR irradiatio...
Status
Recruiting
Location
Zhejiang Hospital
Start Date
2024-01-01
Trial ID
NCT06249750
Treatments Being Tested
The neoadjuvant strategy of immunotherapy combined with chemotherapy has be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-10
Trial ID
NCT07231575
Treatments Being Tested
This is a Phase II, prospective, randomized, open label, controlled, multi-...
Status
Not Yet Recruiting
Location
Tangdu Hospital of the Fourth Millitary Medical University
Start Date
2024-06-30
Trial ID
NCT06475755
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of PD-1 in...
Status
Unknown
Location
Xingchen Peng
Start Date
2022-12-30
Trial ID
NCT05659186
Treatments Being Tested
This is Phase 3, randomized, open-label, parallel controlled study designed...
Status
Unknown
Location
Chinese Academy of Medical Sciences Cancer Hospital
Start Date
2022-01-25
Trial ID
NCT05346952